Evidence map›Paper›PMID 39143605›Full record

ArticleBMC complementary medicine and therapies2024

In vitro-antibacterial properties of ten medicinal plants against common uropathogenic organisms and toxicity determination using brine shrimp lethality assay.

Jayananda Ilangage Maheshi Kavindya Ilangage, Ilangakoon Arachchige Chethana Sewwandi Ilangakoon, Kariyakarawanage Minoshi Kaushika Fernando, Dissanayaka Mudiyanselage Manisha Kavindu Dissanayake, Nimna Pinimali Deeyagaha Rajapaksha, Lakmini Hasanthika Walpola, Dineshani Hettiarachchi

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jayananda Ilangage Maheshi Kavindya IlangageDepartment of Biomedical Science, Faculty of Health Science, Kaatsu International University (KIU), Colombo, Sri Lanka.
Ilangakoon Arachchige Chethana Sewwandi IlangakoonDepartment of Biomedical Science, Faculty of Health Science, Kaatsu International University (KIU), Colombo, Sri Lanka.
Kariyakarawanage Minoshi Kaushika FernandoDepartment of Biomedical Science, Faculty of Health Science, Kaatsu International University (KIU), Colombo, Sri Lanka.
Dissanayaka Mudiyanselage Manisha Kavindu DissanayakeDepartment of Biomedical Science, Faculty of Health Science, Kaatsu International University (KIU), Colombo, Sri Lanka.
Nimna Pinimali Deeyagaha RajapakshaDepartment of Biomedical Science, Faculty of Health Science, Kaatsu International University (KIU), Colombo, Sri Lanka.
Lakmini Hasanthika WalpolaDepartment of Biomedical Science, Faculty of Health Science, Kaatsu International University (KIU), Colombo, Sri Lanka.
Dineshani HettiarachchiDepartment of Anatomy, Genetics and Biomedical Informatics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. dineshani@anat.cmb.ac.lk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, antibiotic resistance has emerged as a global health concern in bacterial infections such as urinary tract infections (UTIs). Uropathogenic Escherichia coli is the most frequent organism responsible for both simple and complex UTIs. Staphylococcus aureus and Pseudomonas aeruginosa are frequently associated with complicated UTIs. Sri Lanka has significant resources of medicinal plants used to cure UTIs in Ayurvedic and traditional medicine.

methodsAgar well diffusion and broth microdilution methods were used to determine the antibacterial activity of the methanolic extract of ten medicinal plants against P. aeruginosa ATCC27853, S.aureus ATCC25923, E.coli ATCC25922 and their UTI positive strains extracted from positive culture plates. As a preliminary toxicity assay, the Brine Shrimp Lethality Assay (BSLA) was used to determine its cytotoxicity.

resultsThe methanolic fruits extract of P. emblica demonstrated the highest antibacterial activity against both E. coli ATCC25922 and E. coli UTI-positive strains. B. diffusa roots extract exhibited the highest activity against S. aureus ATCC25923, while T. chebula fruits extract showed the highest activity against the S. aureus UTI-positive strain. T. involucrata roots extract displayed the highest activity against P. aeruginosa ATCC27853, and Z. officinale rhizomes extract showed the highest activity against the P. aeruginosa UTI-positive strain. Moreover, the plant mixture showed the most substantial antibacterial effect against P. aeruginosa ATCC27853. However, the methanolic seed extract of C. melo did not exhibit any antimicrobial effects against the selected organisms. All plant material, including the plant mixture, showed cytotoxicity according to the BSLA.

conclusionAll the methanolic extracts including P. emblica fruits, O. tenuiflorum whole plant, T. chebula fruits, Z. officinale rhizome, T. terrestris roots, T. involucrata roots, A. lanata whole plant. B. diffusa roots and A. falcatus roots showed antimicrobial effects against selected strains except C. melo seed extract. The results of the present study evidently supports the traditional and ayurvedic use of these plants for the treatment of UTIs. This paves the way for another praise for new plant-based therapeutic product development for the treatment of UTIs. However, further toxicity studies are needed for medicinal dose determination.

Indexed as

Anti-Bacterial AgentsArtemiaMicrobial Sensitivity TestsPlant ExtractsPlants, MedicinalPseudomonas aeruginosaAnimalsSri LankaStaphylococcus aureusUrinary Tract InfectionsAnti-Bacterial AgentsPlant ExtractsAntimicrobialBSLAMedicinal plantUropathogenicUTIs

Identifiers

PMID39143605
PMCPMC11323449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.